24-Hour plasma etoposide profile after oral and intravenous administration in children
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1479-1481
- https://doi.org/10.1016/0959-8049(93)90025-b
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- 'VEEP' in children with Hodgkin's disease – a regimen to decrease late sequelaeBritish Journal of Cancer, 1992
- The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationCancer Chemotherapy and Pharmacology, 1989
- An ELISA for the measurement of VP16 (etoposide) in unextracted plasmaJournal of Immunological Methods, 1988
- In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapyCancer Chemotherapy and Pharmacology, 1987
- Variable bioavailability following repeated oral doses of etoposideEuropean Journal of Cancer and Clinical Oncology, 1985
- Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancerCancer Chemotherapy and Pharmacology, 1982
- Pharmacokinetics of VP16-213 given by different administration methodsCancer Chemotherapy and Pharmacology, 1982